Tuberculosis vaccine passes safety test: study The vaccine candidate VPM1002 shows its safety in a study with HIV- and non-HIV-exposed newborns.
A possible new COVID-19 vaccine could be accessible for more of the world: The protein subunit vaccine, which can be manufactured using engineered yeast, has shown promise in preclinical studies
